GE Healthcare has obtained the US Food and Drug Administration (FDA) 510(k) clearance for its Revolution CT, which will enable physicians to diagnose even the most challenging patients.
Revolution CT scanner is designed to provide an uncompromised image quality and clinical capabilities through the convergence of coverage, spatial resolution and temporal resolution.
The Revolution CT is specifically designed for patients that have high heart rate, metallic implants, and non-compliant patients.
This new technology is able to address these challenging patients by freezing cardiac motion in one heartbeat, reducing metal artifacts, and offering the potential for sedation-free CT scanning.
Additionally, the system also offers benefits for sensitive patient groups such as pediatric, renal insufficiency, trauma, and stroke.
Revolution CT include 16 cm whole organ coverage, best-in-class spatial resolution through the new Gemstone Clarity Detector, and a new gantry designed to image at 0.28s rotation speed and tested to support rotation speeds up to 0.2 sec in the future.
The Revolution CT’s Whisper Drive provides soft ambient lighting, personalized gantry display, and bore pattern to reduce patient anxiety.
Fast and low dose 70 kVp acquisitions for sedation free and minimal breath hold pediatric studies are also now possible.
GE Healthcare MICT president and CEO Steve Gray said this will be the first CT scanner that’s right for physicians in every clinical specialty and provides answers from one CT exam.
"Revolution CT is able to scan even the most challenging patients, day in and day out, with remarkably clear images. It can also scan pediatric patients at very low doses. And, we made sure that using it is productive, logical, and intuitive," Gray added.
GE Healthcare plans worldwide commercial shipments of the Revolution CT this summer.